Regeneron (REGN) r&d spend was $5.9B in FY2025 (+14% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$5.9B
+14%
2024
$5.1B
+16%
2023
$4.4B
+24%
2022
$3.6B
+26%
2021
$2.9B
+8%
2020
$2.6B
+8%
2019
$2.5B
+67%
2018
$1.5B
-29%
2017
$2.1B
+1%
2016
$2.1B
+27%
2015
$1.6B
+27%
2014
$1.3B
+48%
2013
$860M
+37%
2012
$626M
+18%
2011
$530M
+8%
2010
$489M
+23%
2009
$399M
+45%
2008
$275M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q1 2026
$1.5B
Q4 2025
$1.6B
Q3 2025
$1.5B
Q2 2025
$1.4B
Q1 2025
$1.3B
Q4 2024
$1.4B
Q3 2024
$1.3B
Q2 2024
$1.2B
Q1 2024
$1.2B
Q4 2023
$1.2B
Q3 2023
$1.1B
Q2 2023
$1.1B
Source: REGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.